- call +1-201-465-4211
- email sales@mrinsights.biz
Onychomycosis, also known as tinea unguium, is a fungal infection of the nail. Symptoms may include white or yellow nail discoloration, thickening of the nail, and separation of the nail from the nail bed. Toenails or fingernails may be affected, but it is more common for toenails to be affected. Complications may include cellulitis of the lower leg.
Scope of the Report:
This report studies the Onychomycosis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Onychomycosis market by product type and applications/end industries.
Onychomycosis occurs in about 10 percent of the adult population. Older people are more frequently affected. Males are affected more often than females. Onychomycosis represents about half of nail disease.
The global Onychomycosis market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Onychomycosis.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott Laboratories
Glaxosmithkline
Pfizer
Valeant Pharmaceuticals
Galderma
Janssen Biotech
Bristol Meyer Squibb
Topica Pharmaceuticals
Sanofi
Novartis
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Distal Subungual Onychomycosis
White Superficial Onychomycosis
Proximal Subungual Onychomycosis
Candida Onychomycosis
Market Segment by Applications, can be divided into
Children
Male Adults
Female Adults
Senior Citizens
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Onychomycosis Market Overview
1.1 Product Overview and Scope of Onychomycosis
1.2 Classification of Onychomycosis by Types
1.2.1 Global Onychomycosis Revenue Comparison by Types (2017-2023)
1.2.2 Global Onychomycosis Revenue Market Share by Types in 2017
1.2.3 Distal Subungual Onychomycosis
1.2.4 White Superficial Onychomycosis
1.2.5 Proximal Subungual Onychomycosis
1.2.6 Candida Onychomycosis
1.3 Global Onychomycosis Market by Application
1.3.1 Global Onychomycosis Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Children
1.3.3 Male Adults
1.3.4 Female Adults
1.3.5 Senior Citizens
1.4 Global Onychomycosis Market by Regions
1.4.1 Global Onychomycosis Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Onychomycosis Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Onychomycosis Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Onychomycosis Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Onychomycosis Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Onychomycosis Status and Prospect (2013-2023)
1.5 Global Market Size of Onychomycosis (2013-2023)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Onychomycosis Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Onychomycosis Revenue, Gross Margin and Market Share (2016-2017)
2.2 Glaxosmithkline
2.2.1 Business Overview
2.2.2 Onychomycosis Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Glaxosmithkline Onychomycosis Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Onychomycosis Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Onychomycosis Revenue, Gross Margin and Market Share (2016-2017)
2.4 Valeant Pharmaceuticals
2.4.1 Business Overview
2.4.2 Onychomycosis Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Valeant Pharmaceuticals Onychomycosis Revenue, Gross Margin and Market Share (2016-2017)
2.5 Galderma
2.5.1 Business Overview
2.5.2 Onychomycosis Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Galderma Onychomycosis Revenue, Gross Margin and Market Share (2016-2017)
2.6 Janssen Biotech
2.6.1 Business Overview
2.6.2 Onychomycosis Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Janssen Biotech Onychomycosis Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bristol Meyer Squibb
2.7.1 Business Overview
2.7.2 Onychomycosis Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bristol Meyer Squibb Onychomycosis Revenue, Gross Margin and Market Share (2016-2017)
2.8 Topica Pharmaceuticals
2.8.1 Business Overview
2.8.2 Onychomycosis Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Topica Pharmaceuticals Onychomycosis Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sanofi
2.9.1 Business Overview
2.9.2 Onychomycosis Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sanofi Onychomycosis Revenue, Gross Margin and Market Share (2016-2017)
2.10 Novartis
2.10.1 Business Overview
2.10.2 Onychomycosis Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Novartis Onychomycosis Revenue, Gross Margin and Market Share (2016-2017)
3 Global Onychomycosis Market Competition, by Players
3.1 Global Onychomycosis Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Onychomycosis Players Market Share
3.2.2 Top 10 Onychomycosis Players Market Share
3.3 Market Competition Trend
4 Global Onychomycosis Market Size by Regions
4.1 Global Onychomycosis Revenue and Market Share by Regions
4.2 North America Onychomycosis Revenue and Growth Rate (2013-2018)
4.3 Europe Onychomycosis Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Onychomycosis Revenue and Growth Rate (2013-2018)
4.5 South America Onychomycosis Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Onychomycosis Revenue and Growth Rate (2013-2018)
5 North America Onychomycosis Revenue by Countries
5.1 North America Onychomycosis Revenue by Countries (2013-2018)
5.2 USA Onychomycosis Revenue and Growth Rate (2013-2018)
5.3 Canada Onychomycosis Revenue and Growth Rate (2013-2018)
5.4 Mexico Onychomycosis Revenue and Growth Rate (2013-2018)
6 Europe Onychomycosis Revenue by Countries
6.1 Europe Onychomycosis Revenue by Countries (2013-2018)
6.2 Germany Onychomycosis Revenue and Growth Rate (2013-2018)
6.3 UK Onychomycosis Revenue and Growth Rate (2013-2018)
6.4 France Onychomycosis Revenue and Growth Rate (2013-2018)
6.5 Russia Onychomycosis Revenue and Growth Rate (2013-2018)
6.6 Italy Onychomycosis Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Onychomycosis Revenue by Countries
7.1 Asia-Pacific Onychomycosis Revenue by Countries (2013-2018)
7.2 China Onychomycosis Revenue and Growth Rate (2013-2018)
7.3 Japan Onychomycosis Revenue and Growth Rate (2013-2018)
7.4 Korea Onychomycosis Revenue and Growth Rate (2013-2018)
7.5 India Onychomycosis Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Onychomycosis Revenue and Growth Rate (2013-2018)
8 South America Onychomycosis Revenue by Countries
8.1 South America Onychomycosis Revenue by Countries (2013-2018)
8.2 Brazil Onychomycosis Revenue and Growth Rate (2013-2018)
8.3 Argentina Onychomycosis Revenue and Growth Rate (2013-2018)
8.4 Colombia Onychomycosis Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Onychomycosis by Countries
9.1 Middle East and Africa Onychomycosis Revenue by Countries (2013-2018)
9.2 Saudi Arabia Onychomycosis Revenue and Growth Rate (2013-2018)
9.3 UAE Onychomycosis Revenue and Growth Rate (2013-2018)
9.4 Egypt Onychomycosis Revenue and Growth Rate (2013-2018)
9.5 Nigeria Onychomycosis Revenue and Growth Rate (2013-2018)
9.6 South Africa Onychomycosis Revenue and Growth Rate (2013-2018)
10 Global Onychomycosis Market Segment by Type
10.1 Global Onychomycosis Revenue and Market Share by Type (2013-2018)
10.2 Global Onychomycosis Market Forecast by Type (2018-2023)
10.3 Distal Subungual Onychomycosis Revenue Growth Rate (2013-2023)
10.4 White Superficial Onychomycosis Revenue Growth Rate (2013-2023)
10.5 Proximal Subungual Onychomycosis Revenue Growth Rate (2013-2023)
10.6 Candida Onychomycosis Revenue Growth Rate (2013-2023)
11 Global Onychomycosis Market Segment by Application
11.1 Global Onychomycosis Revenue Market Share by Application (2013-2018)
11.2 Onychomycosis Market Forecast by Application (2018-2023)
11.3 Children Revenue Growth (2013-2018)
11.4 Male Adults Revenue Growth (2013-2018)
11.5 Female Adults Revenue Growth (2013-2018)
11.6 Senior Citizens Revenue Growth (2013-2018)
12 Global Onychomycosis Market Size Forecast (2018-2023)
12.1 Global Onychomycosis Market Size Forecast (2018-2023)
12.2 Global Onychomycosis Market Forecast by Regions (2018-2023)
12.3 North America Onychomycosis Revenue Market Forecast (2018-2023)
12.4 Europe Onychomycosis Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Onychomycosis Revenue Market Forecast (2018-2023)
12.6 South America Onychomycosis Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Onychomycosis Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Onychomycosis Picture
Table Product Specifications of Onychomycosis
Table Global Onychomycosis and Revenue (Million USD) Market Split by Product Type
Fi
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
